List of Excipients in API olmesartan medoxomil
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing olmesartan medoxomil
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Cosette Pharmaceuticals Inc | BENICAR | olmesartan medoxomil | 0713-0860 | CELLULOSE, MICROCRYSTALLINE | |
| Cosette Pharmaceuticals Inc | BENICAR | olmesartan medoxomil | 0713-0860 | FERRIC OXIDE YELLOW | |
| Cosette Pharmaceuticals Inc | BENICAR | olmesartan medoxomil | 0713-0860 | HYDROXYPROPYL CELLULOSE | |
| Cosette Pharmaceuticals Inc | BENICAR | olmesartan medoxomil | 0713-0860 | HYPROMELLOSE | |
| Cosette Pharmaceuticals Inc | BENICAR | olmesartan medoxomil | 0713-0860 | LACTOSE MONOHYDRATE | |
| Cosette Pharmaceuticals Inc | BENICAR | olmesartan medoxomil | 0713-0860 | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | |
| Cosette Pharmaceuticals Inc | BENICAR | olmesartan medoxomil | 0713-0860 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing olmesartan medoxomil
Detailed excipient profiles for olmesartan medoxomil
Excipient focus: CELLULOSE, MICROCRYSTALLINE
olmesartan medoxomil drug variants containing CELLULOSE, MICROCRYSTALLINE
olmesartan medoxomil drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
olmesartan medoxomil drug variants containing CROSCARMELLOSE SODIUM
olmesartan medoxomil drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
olmesartan medoxomil drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | olmesartan medoxomil | 71335-0999 |
| Teva Pharmaceuticals USA Inc | olmesartan medoxomil, amlodipine and hydrochlorothiazide | 0093-5005 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil drug variants not containing CROSPOVIDONE
Excipient focus: FD&C BLUE NO. 1
olmesartan medoxomil drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare US LLC | olmesartan medoxomil | 43547-299 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C RED NO. 40
olmesartan medoxomil drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare US LLC | olmesartan medoxomil | 43547-299 |
| Teva Pharmaceuticals USA Inc | olmesartan medoxomil, amlodipine and hydrochlorothiazide | 0093-5005 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
olmesartan medoxomil drug variants containing FD&C YELLOW NO. 6
olmesartan medoxomil drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
olmesartan medoxomil drug variants containing FERRIC OXIDE RED
olmesartan medoxomil drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
olmesartan medoxomil drug variants containing FERRIC OXIDE YELLOW
olmesartan medoxomil drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
olmesartan medoxomil drug variants containing FERROSOFERRIC OXIDE
olmesartan medoxomil drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROGENATED CASTOR OIL
olmesartan medoxomil drug variants containing HYDROGENATED CASTOR OIL
olmesartan medoxomil drug variants not containing HYDROGENATED CASTOR OIL
Excipient focus: HYDROXYPROPYL CELLULOSE
olmesartan medoxomil drug variants containing HYDROXYPROPYL CELLULOSE
olmesartan medoxomil drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
olmesartan medoxomil drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
olmesartan medoxomil drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: HYPROMELLOSE
olmesartan medoxomil drug variants containing HYPROMELLOSE
olmesartan medoxomil drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
olmesartan medoxomil drug variants containing HYPROMELLOSE 2208
olmesartan medoxomil drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
olmesartan medoxomil drug variants containing HYPROMELLOSE 2910
olmesartan medoxomil drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
olmesartan medoxomil drug variants containing HYPROMELLOSES
olmesartan medoxomil drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
olmesartan medoxomil drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | olmesartan medoxomil and hydrochlorothiazide | 54868-5170 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
olmesartan medoxomil drug variants containing LACTOSE MONOHYDRATE
olmesartan medoxomil drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
olmesartan medoxomil drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
olmesartan medoxomil drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Excipient focus: MAGNESIUM STEARATE
olmesartan medoxomil drug variants containing MAGNESIUM STEARATE
olmesartan medoxomil drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | olmesartan medoxomil | 68382-643 |
| Zydus Lifesciences Limited | olmesartan medoxomil | 70771-1059 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
olmesartan medoxomil drug variants containing MICROCRYSTALLINE CELLULOSE 101
olmesartan medoxomil drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
olmesartan medoxomil drug variants containing MICROCRYSTALLINE CELLULOSE 102
olmesartan medoxomil drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: POLYETHYLENE GLYCOL
olmesartan medoxomil drug variants containing POLYETHYLENE GLYCOL
olmesartan medoxomil drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 1000
olmesartan medoxomil drug variants containing POLYETHYLENE GLYCOL 1000
olmesartan medoxomil drug variants not containing POLYETHYLENE GLYCOL 1000
Excipient focus: POLYETHYLENE GLYCOL 3350
olmesartan medoxomil drug variants containing POLYETHYLENE GLYCOL 3350
olmesartan medoxomil drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
olmesartan medoxomil drug variants containing POLYETHYLENE GLYCOL 400
olmesartan medoxomil drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 4000
olmesartan medoxomil drug variants containing POLYETHYLENE GLYCOL 4000
olmesartan medoxomil drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 6000
olmesartan medoxomil drug variants containing POLYETHYLENE GLYCOL 6000
olmesartan medoxomil drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
olmesartan medoxomil drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | olmesartan medoxomil | 0378-7012 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYSORBATE 20
olmesartan medoxomil drug variants containing POLYSORBATE 20
olmesartan medoxomil drug variants not containing POLYSORBATE 20
Excipient focus: POLYVINYL ALCOHOL
olmesartan medoxomil drug variants containing POLYVINYL ALCOHOL
olmesartan medoxomil drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE K30
olmesartan medoxomil drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olmesartan medoxomil, amlodipine and hydrochlorothiazide | 0093-5005 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
olmesartan medoxomil drug variants containing SILICON DIOXIDE
olmesartan medoxomil drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
olmesartan medoxomil drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | olmesartan medoxomil | 0378-7012 |
| Bryant Ranch Prepack | olmesartan medoxomil and hydrochlorothiazide | 63629-7278 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
olmesartan medoxomil drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
olmesartan medoxomil drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
olmesartan medoxomil drug variants containing STARCH, CORN
olmesartan medoxomil drug variants not containing STARCH, CORN
Excipient focus: STEARIC ACID
olmesartan medoxomil drug variants containing STEARIC ACID
olmesartan medoxomil drug variants not containing STEARIC ACID
Excipient focus: SUCCINIMIDYL-4-(N-MALEIMIDOMETHYL)CYCLOHEXANE-1-CARBOXYLATE
olmesartan medoxomil drug variants containing SUCCINIMIDYL-4-(N-MALEIMIDOMETHYL)CYCLOHEXANE-1-CARBOXYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg | 13668-397 |
| REMEDYREPACK INC | olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg | 70518-2647 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil drug variants not containing SUCCINIMIDYL-4-(N-MALEIMIDOMETHYL)CYCLOHEXANE-1-CARBOXYLATE
Excipient focus: TALC
olmesartan medoxomil drug variants containing TALC
olmesartan medoxomil drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
olmesartan medoxomil drug variants containing TITANIUM DIOXIDE
olmesartan medoxomil drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
olmesartan medoxomil drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare US LLC | olmesartan medoxomil | 43547-299 |
| Bryant Ranch Prepack | olmesartan medoxomil | 71335-2399 |
| Direct_rx | olmesartan medoxomil | 72189-558 |
| >Company | >Ingredient | >NDC |
olmesartan medoxomil drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
